Jade Biosciences, Inc.
JBIO- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001798749
No open-market purchases or sales by Jade Biosciences, Inc. insiders were filed in the last 90 days; 153 institutions reported holding it in 13F filings for Q2 2026, worth $1.62B in total; no superinvestor holds it.
13F holders, Q2 2022
Institutional positions in Jade Biosciences, Inc. as of Jun 30, 2022. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 51
- +7 vs. Q1 2022
- Shares held
- 25.8M
- −140.2K (−0.5%) vs. Q1 2022
- Total value
- $403.0M
- −$72.1M (−15.2%) vs. Q1 2022
- New holders
- 9
- 7 more added
- Sold out
- 2
- 25 more reduced
2 institutions that held it in Q1 2022 haven't filed for Q2 2022 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q1 2022: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting JBIO on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 153 | $1.62B |
| Q1 2026 | 120 | $700.3M |
| Q4 2025 | 105 | $726.3M |
| Q3 2025 | 78 | $272.9M |
| Q2 2025 | 75 | $315.1M |
| Q1 2025 | 82 | $79.6M |
| Q4 2024 | 80 | $79.9M |
| Q3 2024 | 75 | $57.8M |
| Q2 2024 | 81 | $45.1M |
| Q1 2024 | 81 | $841.5M |
| Q4 2023 | 64 | $637.8M |
| Q3 2023 | 58 | $386.3M |
| Q2 2023 | 60 | $488.3M |
| Q1 2023 | 66 | $524.1M |
| Q4 2022 | 70 | $802.9M |
| Q3 2022 | 56 | $447.4M |
| Q2 2022 | 51 | $403.0M |
| Q1 2022 | 46 | $475.5M |
| Q4 2021 | 47 | $301.6M |
| Q3 2021 | 41 | $452.6M |
| Q2 2021 | 18 | $454.4M |
| Q1 2021 | 0 | $0 |
Institutions, Q2 2022
Shares, value and share of portfolio for each institution holding Jade Biosciences, Inc.; share changes are against Q1 2022.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Ellevest, Inc. | 13 | $0 | 0.00% | 00.0% | Unchanged |
| Credit Suisse AG | 11 | $0 | 0.00% | +11 | New |
| Royal Bank of Canada | 52 | $1.00K | 0.00% | −752−93.5% | Reduced |
| Daiwa Securities Group Inc. | 73 | $1.00K | 0.00% | 00.0% | Unchanged |
| FinTrust Capital Advisors, LLC | 82 | $1.00K | 0.00% | +82 | New |
| Wells Fargo & Company | 118 | $2.00K | 0.00% | −1,379−92.1% | Reduced |
| Legal & General Group Plc | 414 | $6.00K | 0.00% | −927−69.1% | Reduced |
| Tower Research Capital LLC (TRC) | 515 | $8.00K | 0.00% | −903−63.7% | Reduced |
| Ameritas Investment Partners, Inc. | 772 | $12.0K | 0.00% | 00.0% | Unchanged |
| Citigroup Inc | 1,078 | $17.0K | 0.00% | −342−24.1% | Reduced |
| Amalgamated Bank | 1,199 | $19.0K | 0.00% | −263−18.0% | Reduced |
| Bank of America Corp | 2,031 | $32.0K | 0.00% | −2,072−50.5% | Reduced |
| Russell Investments Group, Ltd. | 2,056 | $32.0K | 0.00% | +2,056 | New |
| STRS Ohio | 2,300 | $35.0K | 0.00% | 00.0% | Unchanged |
| California State Teachers Retirement System | 3,927 | $61.0K | 0.00% | −1,675−29.9% | Reduced |
| Barclays PLC | 4,024 | $63.0K | 0.00% | −1,763−30.5% | Reduced |
| American International Group, Inc. | 4,297 | $67.0K | 0.00% | −2,197−33.8% | Reduced |
| Deutsche Bank AG | 4,342 | $68.0K | 0.00% | −1,104−20.3% | Reduced |
| New York State Common Retirement Fund | 5,186 | $81.0K | 0.00% | −7,405−58.8% | Reduced |
| JPMorgan Chase & Co | 5,876 | $92.0K | 0.00% | −3,131−34.8% | Reduced |
| Morgan Stanley | 7,929 | $124.0K | 0.00% | +370+4.9% | Added |
| Jane Street Group, LLC | 11,717 | $183.0K | 0.00% | +11,717 | New |
| Rhumbline Advisers | 13,193 | $206.0K | 0.00% | +13,193 | New |
| Chicago Partners Investment Group LLC | 10,163 | $226.0K | 0.02% | +10,163 | New |
| Ergoteles LLC | 18,000 | $281.0K | 0.01% | +18,000 | New |
| Charles Schwab Investment Management Inc | 23,836 | $373.0K | 0.00% | −9,017−27.4% | Reduced |
| Millennium Management LLC | 24,066 | $376.0K | 0.00% | +24,066 | New |
| Bank of New York Mellon Corp | 25,067 | $392.0K | 0.00% | −5,420−17.8% | Reduced |
| Parkwood LLC | 32,414 | $507.0K | 0.10% | +32,414 | New |
| Nuveen Asset Management, LLC | 38,788 | $606.0K | 0.00% | +24,470+170.9% | Added |
| Skandinaviska Enskilda Banken AB (publ) | 56,431 | $882.0K | 0.01% | +42,323+300.0% | Added |
| Northern Trust Corp | 76,140 | $1.19M | 0.00% | −28,310−27.1% | Reduced |
| Adage Capital Partners GP, L.L.C. | 100,000 | $1.56M | 0.00% | 00.0% | Unchanged |
| Geode Capital Management, LLC | 166,162 | $2.60M | 0.00% | −29,025−14.9% | Reduced |
| Fred Alger Management, LLC | 172,706 | $2.70M | 0.01% | +5,699+3.4% | Added |
| State Street Corp | 178,554 | $2.79M | 0.00% | +10,517+6.3% | Added |
| Lynx1 Capital Management LP | 191,565 | $2.99M | 2.55% | +124,588+186.0% | Added |
| Sectoral Asset Management Inc | 196,038 | $3.06M | 0.62% | −22,875−10.4% | Reduced |
| Vanguard Group Inc | 442,401 | $6.92M | 0.00% | −37,709−7.9% | Reduced |
| OrbiMed Advisors LLC | 478,579 | $7.48M | 0.15% | −31,370−6.2% | Reduced |
| VR Adviser, LLC | 590,408 | $9.23M | 1.82% | +439,371+290.9% | Added |
| OUP Management Co., LLC | 603,762 | $9.44M | 12.99% | 00.0% | Unchanged |
| FMR LLC | 634,766 | $9.92M | 0.00% | −84,708−11.8% | Reduced |
| BlackRock Inc. | 705,368 | $11.0M | 0.00% | −41,566−5.6% | Reduced |
| TCG Crossover Management, LLC | 889,572 | $13.9M | 5.91% | 00.0% | Unchanged |
| Citadel Advisors LLC | 1,592,009 | $24.9M | 0.03% | −1,367−0.1% | Reduced |
| Cormorant Asset Management, LP | 1,730,691 | $27.1M | 2.10% | −100,000−5.5% | Reduced |
| Baker Bros. Advisors LP | 2,070,010 | $32.4M | 0.18% | 00.0% | Unchanged |
| Atlas Venture Life Science Advisors, LLC | 2,638,297 | $41.2M | 6.89% | −465,582−15.0% | Reduced |
| Sofinnova Investments, Inc. | 3,758,686 | $58.7M | 5.23% | 00.0% | Unchanged |
| Ra Capital Management, L.P. | 8,263,982 | $129.2M | 3.44% | 00.0% | Unchanged |
| Penn Mutual Asset Management, LLC | 0 | $0 | 0.00% | −17,458−100.0% | Sold out |
| Allspring Global Investments Holdings, LLC | 0 | $0 | 0.00% | −953−100.0% | Sold out |
| Golden State Equity Partners | – | – | – | – | Not filed |
| Amalgamated Financial Corp. | – | – | – | – | Not filed |